Antisense strategies in leukemias

The experimentation of antisense oligos isrecently been carried out in laboratory animalsand in clinical trials of patients having differenthematological neoplastic diseases. In the futureit will be probably possible to reach one of themore desired goal in cancer therapy: specificityof act ion and s e l e c t ive ce l l d e a th o f c ance rcells.